Status:
COMPLETED
Dermal Phototoxicity Study
Lead Sponsor:
Vyne Therapeutics Inc.
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Dermal Safety study to determine the Phototoxicity Potential of FMX-101 4% in Healthy Volunteers
Eligibility Criteria
Inclusion
- Healthy male or female volunteers age 18 years or older
- Has uniformly-colored skin on the lower thoracic area of the back which allowed discernment of erythema, and were Fitzpatrick Skin Types I, II, or III
Exclusion
- Has any visible disease at the application site which, in the opinion of the investigative personnel, would have interfered with the evaluation of the test site reaction
- Are unwilling or unable to refrain from the use of sunscreens, cosmetics, creams, ointments, lotions or similar products on the back during the study
Key Trial Info
Start Date :
August 17 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04070742
Start Date
August 17 2016
End Date
October 1 2016
Last Update
September 11 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.